Literature DB >> 29697544

The role of the pharmacist in hypertension management.

Katherine E Di Palo1, Troy Kish2.   

Abstract

PURPOSE OF REVIEW: Hypertension remains a vital, modifiable risk factor in the prevention of cardiovascular disease. However, many patients do not achieve their therapeutic goals for numerous reasons which can include poor disease insight and nonadherence. Pharmacists can be key players in controlling hypertension, given their medication knowledge and patient counseling skills, yet they remain an underutilized resource in the management of chronic disease states. Various models exist that allow pharmacists to provide direct patient-centered care but practices differ from state to state since pharmacists are not recognized nationally as healthcare providers. This article aims to provide an update on the proven methods in which pharmacists contribute to the management of hypertensive patients. RECENT
FINDINGS: Several recently published studies demonstrate the positive impact of pharmacist intervention and care on patient outcomes in ambulatory and community settings. These practice models include medication therapy management, collaborative drug therapy management, telehealth and team-based care.
SUMMARY: The role of the pharmacist in hypertension encompasses medication management, disease state education and patient counseling and is most successful when integrated into the patient's care team. Further validation through larger, prospective trials and evaluation of long-term outcomes, such as mortality, remain viable research opportunities.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29697544     DOI: 10.1097/HCO.0000000000000527

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

Review 1.  Physician-pharmacist collaborative practice and telehealth may transform hypertension management.

Authors:  Stefano Omboni; Mauro Tenti; Claudio Coronetti
Journal:  J Hum Hypertens       Date:  2018-12-13       Impact factor: 3.012

2.  Community Pharmacists' Perceptions of Patient Care Services within an Enhanced Service Network.

Authors:  Christopher J Daly; Bryan Quinn; Anna Mak; David M Jacobs
Journal:  Pharmacy (Basel)       Date:  2020-09-16

3.  Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China.

Authors:  Ying Li; Guoqin Liu; Chaojie Liu; Xianhong Wang; Yalin Chu; Xiaoqin Li; Wenhao Yang; Yewei Shen; Fang Wu; Wenzhi Zhang
Journal:  Glob Health Sci Pract       Date:  2021-12-21

Review 4.  Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders.

Authors:  Eric M Tichy; Barbara Prosser; Drew Doyle
Journal:  J Pharm Pract       Date:  2020-07-17

5.  An investigation of new medications initiation during ambulatory care visits in patients with dementia.

Authors:  Alexandra Wallem; Ashley I Martinez; Lauren Vickers; Michael Singleton; Daniela C Moga
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-08

6.  Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.

Authors:  Martin Schulz; Nina Griese-Mammen; Pia M Schumacher; Dorothea Strauch; Leonard Freudewald; André Said; Ross T Tsuyuki; Ulrich Laufs; Ulrich Kintscher; Michael Böhm; Felix Mahfoud
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-30       Impact factor: 3.738

Review 7.  The current state and future of internet technology-based hypertension management in Japan.

Authors:  Junichi Yatabe; Midori Sasaki Yatabe; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-12-23       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.